While Chief Scientist Alan Finkel’s review of contact tracing only briefly mentions digital methods, it’s crucial Australia invests in an automated system.
Academics and others concerned with benefitting from peer professional collaboration can use COVID-19 disruptions as an opportunity to improve conferences through smart design.
In the current pandemic, finding the right balance between the protection of public health and respecting civil liberties has proven to be supremely difficult.
South Australia’s COVID cluster is disappointing after a long stretch of no community transmission. Now we need to act to stop it growing exponentially.
To navigate the toughest phase of their careers, junior academics need to know more than how to write research papers and apply for grants. Structured mentoring, based on their input, is a huge help.
Distributing a vaccine is a bit like boarding a plane — we can’t all board at the same time. So who gets priority? There are a few reasons we should consider vaccinating older people first.
There’s no guarantee future COVID-19 vaccines will work in the elderly. So we can consider vaccinating the young first to protect them. Here’s what we need to work out first.
COVID led to commuting time savings worth over $2,000 a year for each driver and $5,000 per public transport user. But as workplaces reopen, we may need road user charges to keep traffic flowing.
Most people who received some money experienced less hunger, sickness and depression, both before and after Kenya imposed restrictions in the pandemic.
Aïssatou Aïcha Sow, Institut national de la recherche scientifique (INRS)
Canada has set aside a total of 414 million doses of different types of vaccine. Some exploit known mechanisms, others are based on previously untested approaches.
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand